Acquired cerebral hemiatrophy: idiopathic?

Neeraj Kumar1, Edward P Lindell, John D Port

  • 1Department of Neurology, Mayo Clinic, Rochester, MN, USA. kumar.neeraj@mayo.edu

Insights

This case study describes a young man with acquired cerebral hemiatrophy, possibly linked to an unidentified inflammatory or infectious condition. Further research may expand the understanding of Rasmussen

Area of Science:

  • Neurology
  • Neuroscience
  • Medical Case Reports

Background:

  • Acquired cerebral hemiatrophy is a rare neurological condition characterized by progressive unilateral brain atrophy.
  • Etiologies are diverse, often involving vascular events, infections, or inflammatory processes.
  • Rasmussen's encephalitis is a known cause, typically presenting with intractable epilepsy and cognitive decline.

Observation:

  • A young male patient presented with initially progressive, then stabilizing, acquired cerebral hemiatrophy.
  • The patient experienced no seizures during the illness.
  • Extensive investigations failed to reveal a definitive cause, but cerebrospinal fluid analysis showed a mild pleocytosis during the progressive phase.

Findings:

  • The clinical course and findings suggest an underlying unidentified infective or inflammatory process.
  • The case challenges typical presentations of Rasmussen's encephalitis, suggesting it may represent a spectrum of disease.
  • Multimodality imaging proved crucial in the diagnostic evaluation of cerebral hemiatrophy.

Implications:

  • This case expands the potential spectrum of Rasmussen's encephalitis beyond typical epileptic presentations.
  • Highlights the importance of considering inflammatory/infectious etiologies even without seizures in cerebral hemiatrophy.
  • Underscores the value of advanced neuroimaging techniques in diagnosing complex neurological conditions.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...